Evidence map›Paper›PMID 31712349›Full record

ArticleBMJ open2019

Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.

Antoine Villa, Mathieu Molimard, Emmanuelle Bignon, Béatrice Martinez, Magali Rouyer, Simone Mathoulin-Pelissier, Isabelle Baldi, Catherine Verdun-Esquer, Mireille Canal-Raffin

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03137641 (Assessment of Nurses Internal Contamination by Antineoplastic Drugs in Hospital Centers.), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03137641 completednot on this map

Assessment of Nurses Internal Contamination by Antineoplastic Drugs in Hospital Centers.

TypeobservationalSponsorUniversity Hospital, BordeauxRan2017 to 2019Enrolled72ConditionsAntineoplastic Drugs Contamination PrevalenceArmsNurses urine samples
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antoine VillaInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Mathieu MolimardInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Emmanuelle BignonBordeaux PharmacoEpi (BPE, CIC 1401), Université de Bordeaux, Talence, France.
Béatrice MartinezInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Magali RouyerBordeaux PharmacoEpi (BPE, CIC 1401), Université de Bordeaux, Talence, France.
Simone Mathoulin-PelissierInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Isabelle BaldiInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Catherine Verdun-EsquerGH Pellegrin, Pôle de Santé Publique, Service de Médecine du Travail et Pathologies professionnelles, CHU de Bordeaux, Bordeaux, France.
Mireille Canal-RaffinInserm U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France mireille.canal-raffin@u-bordeaux.fr.ORCID 0000-0003-4140-1639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntineoplastic drugs (AD) are potentially carcinogenic and/or reprotoxic molecules. Healthcare professionals are increasingly exposed to these drugs and can be potentially contaminated by them. Internal contamination of professionals is a key concern for occupational physicians in the assessment and management of occupational risks in healthcare settings. Objectives of this study are to report AD internal contamination rate in nursing staff and to identify factors associated with internal contamination. METHODS AND ANALYSIS: This trial will be conducted in two French hospital centres: University Hospital of Bordeaux and IUCT-Oncopole of Toulouse. The target population is nurses practicing in one of the fifteen selected care departments where at least one of the five studied AD is handled (5-fluorouracil, cyclophosphamide, doxorubicin, ifosfamide, methotrexate). The trial will be conducted with the following steps: (1) development of analytical methods to quantify AD urine biomarkers, (2) study of the workplace and organization around AD in each care department (transport and handling, professional practices, personal and collective protection equipments available) (3) development of a self-questionnaire detailing professional activities during the day of inclusion, (4) nurses inclusion (urine samples and self-questionnaire collection), (5) urine assays, (6) data analysis. ETHICS AND DISSEMINATION: The study protocol has been approved by the French Advisory Committee on the Treatment of Information in Health Research (CCTIRS) and by the French Data Protection Authority (CNIL). Following the opinion of the Regional Committee for the Protection of Persons, this study is outside the scope of the provisions governing biomedical research and routine care (n°2014/87). The results will be submitted to peer-reviewed journals and reported at suitable national and international meetings. TRIAL REGISTRATION NUMBER: NCT03137641.

Indexed as

Nursing Staff, HospitalAntineoplastic AgentsBiomarkersCross-Sectional StudiesCyclophosphamideDoxorubicinEnvironmental MonitoringFluorouracilFranceHumansIfosfamideMethotrexateMulticenter Studies as TopicObservational Studies as TopicOccupational ExposureOncology NursingAntineoplastic AgentsBiomarkersCyclophosphamideDoxorubicinFluorouracilIfosfamideMethotrexateantineoplastic drugsbiomonitoringnursesoccupational exposureoccupational & industrial medicineurine

Identifiers

PMID31712349
PMCPMC6858204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.